Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

The journey from the old to the new AMH assay: how to avoid getting lost in the values.

Nelson SM, La Marca A.

Reprod Biomed Online. 2011 Oct;23(4):411-20. doi: 10.1016/j.rbmo.2011.06.011. Epub 2011 Jun 28. Review.

PMID:
21872528
2.

Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.

Broer SL, Eijkemans MJ, Scheffer GJ, van Rooij IA, de Vet A, Themmen AP, Laven JS, de Jong FH, Te Velde ER, Fauser BC, Broekmans FJ.

J Clin Endocrinol Metab. 2011 Aug;96(8):2532-9. doi: 10.1210/jc.2010-2776. Epub 2011 May 25.

PMID:
21613357
3.

Antimüllerian hormone and polycystic ovary syndrome.

Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, Hsu MI.

Fertil Steril. 2011 Jul;96(1):230-5. doi: 10.1016/j.fertnstert.2011.04.003. Epub 2011 May 5.

PMID:
21549367
4.

Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years.

Steiner AZ, Herring AH, Kesner JS, Meadows JW, Stanczyk FZ, Hoberman S, Baird DD.

Obstet Gynecol. 2011 Apr;117(4):798-804. doi: 10.1097/AOG.0b013e3182116bc8.

5.

Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer.

Anderson RA, Cameron DA.

J Clin Endocrinol Metab. 2011 May;96(5):1336-43. doi: 10.1210/jc.2010-2582. Epub 2011 Feb 16.

PMID:
21325458
6.

Fertility and ovarian function in high-dose estrogen-treated tall women.

Hendriks AE, Laven JS, Valkenburg O, Fong SL, Fauser BC, de Ridder MA, de Jong FH, Visser JA, van Ginneken AM, Boot AM, Drop SL.

J Clin Endocrinol Metab. 2011 Apr;96(4):1098-105. doi: 10.1210/jc.2010-2244. Epub 2011 Feb 2.

PMID:
21289262
7.

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States.

Seifer DB, Baker VL, Leader B.

Fertil Steril. 2011 Feb;95(2):747-50. doi: 10.1016/j.fertnstert.2010.10.011. Epub 2010 Nov 13.

PMID:
21074758
8.

The reproducibility of serum anti-Müllerian hormone in subfertile women: within and between patient variability.

Rustamov O, Pemberton PW, Roberts SA, Smith A, Yates AP, Patchava SD, Nardo LG.

Fertil Steril. 2011 Mar 1;95(3):1185-7. doi: 10.1016/j.fertnstert.2010.10.001. Epub 2010 Oct 30.

PMID:
21036350
9.

Development of a second generation anti-Müllerian hormone (AMH) ELISA.

Kumar A, Kalra B, Patel A, McDavid L, Roudebush WE.

J Immunol Methods. 2010 Oct 31;362(1-2):51-9. doi: 10.1016/j.jim.2010.08.011. Epub 2010 Aug 27.

PMID:
20801125
10.

Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.

Sowers MR, McConnell D, Yosef M, Jannausch ML, Harlow SD, Randolph JF Jr.

Ann N Y Acad Sci. 2010 Aug;1204:95-103. doi: 10.1111/j.1749-6632.2010.05523.x.

11.

Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients.

Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, Cleemann L, Holm K, Gravholt CH, Andersson AM, Pedersen AT, Petersen JH, Linneberg A, Kjaergaard S, Juul A.

J Clin Endocrinol Metab. 2010 Nov;95(11):5003-10. doi: 10.1210/jc.2010-0930. Epub 2010 Aug 18.

PMID:
20719830
12.

The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial.

Mutsaerts MA, Groen H, ter Bogt NC, Bolster JH, Land JA, Bemelmans WJ, Kuchenbecker WK, Hompes PG, Macklon NS, Stolk RP, van der Veen F, Maas JW, Klijn NF, Kaaijk EM, Oosterhuis GJ, Bouckaert PX, Schierbeek JM, van Kasteren YM, Nap AW, Broekmans FJ, Brinkhuis EA, Koks CA, Burggraaff JM, Blankhart AS, Perquin DA, Gerards MH, Mulder RJ, Gondrie ET, Mol BW, Hoek A.

BMC Womens Health. 2010 Jun 25;10:22. doi: 10.1186/1472-6874-10-22.

13.

Correlation of ovarian reserve tests with histologically determined primordial follicle number.

Hansen KR, Hodnett GM, Knowlton N, Craig LB.

Fertil Steril. 2011 Jan;95(1):170-5. doi: 10.1016/j.fertnstert.2010.04.006. Epub 2010 Jun 1.

PMID:
20522327
14.

The adverse effects of obesity on conception and implantation.

Brewer CJ, Balen AH.

Reproduction. 2010 Sep;140(3):347-64. doi: 10.1530/REP-09-0568. Epub 2010 Apr 15. Review.

15.

Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.

Decanter C, Morschhauser F, Pigny P, Lefebvre C, Gallo C, Dewailly D.

Reprod Biomed Online. 2010 Feb;20(2):280-5. doi: 10.1016/j.rbmo.2009.11.010. Epub 2009 Dec 3.

PMID:
20113967
16.

The impact of smoking on antimüllerian hormone levels in women aged 38 to 50 years.

Plante BJ, Cooper GS, Baird DD, Steiner AZ.

Menopause. 2010 May-Jun;17(3):571-6. doi: 10.1097/gme.0b013e3181c7deba.

17.

Validity of self-reported time to pregnancy.

Joffe M.

Epidemiology. 2010 Jan;21(1):160-1; author reply 161. doi: 10.1097/EDE.0b013e3181c1ec69. No abstract available.

PMID:
20010224
18.

An internet-based prospective study of body size and time-to-pregnancy.

Wise LA, Rothman KJ, Mikkelsen EM, Sørensen HT, Riis A, Hatch EE.

Hum Reprod. 2010 Jan;25(1):253-64. doi: 10.1093/humrep/dep360. Epub 2009 Oct 14.

19.

Longitudinal assessment of antimüllerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin.

Nelson SM, Stewart F, Fleming R, Freeman DJ.

Fertil Steril. 2010 Mar 1;93(4):1356-8. doi: 10.1016/j.fertnstert.2009.07.1676. Epub 2009 Oct 1.

PMID:
19800062
20.

Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).

La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A.

Hum Reprod Update. 2010 Mar-Apr;16(2):113-30. doi: 10.1093/humupd/dmp036. Epub 2009 Sep 30. Review.

Items per page

Supplemental Content

Write to the Help Desk